Qube Research & Technologies (QRT)
IMDX

Qube Research & Technologies (QRT)’s Insight Molecular Diagnostics IMDX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio IMDX Stock Details IMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-25,230
Closed -$82.8K – 3893
2026
Q1 		$82.8K Sell
25,230
-3,121
-11% -$18.1K ﹤0.01% 3093
2025
Q4 		$213K Buy
+28,351
New +$160K ﹤0.01% 3043
2024
Q3 		– Sell
-1
Closed -$3 – 3873
2024
Q2 		$3 Hold
1
– – ﹤0.01% 3674
2024
Q1 		$3 Hold
1
– – ﹤0.01% 4350
2023
Q4 		$2 Hold
1
– – ﹤0.01% 4244
2023
Q3 		$3 Buy
+1
New +$4 ﹤0.01% 3990
2022
Q4 		– Sell
-2,720
Closed -$40K – 2842
2022
Q3 		$40K Sell
2,720
-207
-7% -$3.58K ﹤0.01% 2183
2022
Q2 		$53K Buy
+2,927
New +$66.6K ﹤0.01% 2110

Other funds holding IMDX

BC
Broadwood Capital New York $1.91B AUM 44.39% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
FOR
Family Office Research Bethesda, Maryland $267M AUM 27.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Qube Research & Technologies (QRT)'s IMDX Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Insight Molecular Diagnostics (IMDX) in Q2 2026, closing a stake of 25,230 shares — an estimated $82.8K sold.

Qube Research & Technologies (QRT) first reported a position in IMDX in Q2 2022 and held it in 8 quarters. The position peaked at $213K in Q4 2025. 40 funds tracked by Wall St. Rank hold IMDX as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Insight Molecular Diagnostics position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 25,230 Insight Molecular Diagnostics shares in Q2 2026, an estimated $82.8K.
  • Qube Research & Technologies (QRT) first reported a position in Insight Molecular Diagnostics in Q2 2022 and held it in 8 quarters.
  • Qube Research & Technologies (QRT)'s Insight Molecular Diagnostics position peaked at $213K in Q4 2025.
  • 40 funds tracked by Wall St. Rank held Insight Molecular Diagnostics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.